The Maharashtra government has
decided to set up district-level control rooms to ensure smooth supply of Remdesivir injections and prevent hoarding and black-marketing of the drug, officials said on Sunday.
Remdesivir is considered a key medicine in the fight against COVID-19, especially in adult patients with severe complications.
The state is facing multiple issues pertaining to the drug, like demand-supply gap, its hoarding and black-marketing by stockists and pharmacy shops, unaffordable prices and irrational prescription by some doctors.
Maharashtra's health services commissioner Ramaswami N, in a letter dated April 9, has written to all district collectors in the state to set up control rooms to streamline the supply of the key anti-viral drug.
Chief Minister Uddhav Thackeray recently reviewed the situation with state Health Minister Rajesh Tope, Medical Education Minister Amit Deshmukh, Food and Drug Administration (FDA) Minister Rajendra Shingne and Urban Development Minister Eknath Shinde.
The government has asked authorities to cap the price of Remdesivir between Rs 1,100 and Rs 1,400 per vial and urged about a dozen pharmaceutical companies manufacturing the drug to ramp-up its production and lower its MRP (maximum retail price).
It has also asked the health services commissioner to put in place a separate mechanism to streamline the supply of Remdesivir, in the wake of a rise in its demand due to a surge in COVID-19 cases.
Ramaswami, who is also the state's mission director of the National Health Mission, has directed the FDA to contact the state-level control room and take appropriate action, if needed, in case of any issue regarding the supply of the medicine.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
"smooth" - Google News
April 11, 2021 at 02:47PM
https://ift.tt/3a2DOjx
Maharashtra to set up control rooms for smooth supply of Remdesivir - Business Standard
"smooth" - Google News
https://ift.tt/30JhCVH
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "Maharashtra to set up control rooms for smooth supply of Remdesivir - Business Standard"
Post a Comment